Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Vosevi“
Suchtreffer
Begriffe & Kennungen
Vosevi · 4.5 · 15 Medicinal product by Effects on medicinal product levels. therapeutic areas/Possible Mean ratio (90% confid
Eintrag öffnenVosevi · 4.5 · 16 h. Administered as sofosbuvir, velpatasvir fixed-dose combination. i. Administered as emtricitabine, rilpiv
Eintrag öffnenVosevi · 4.5 · 6 Pharmacodynamic interactions
Eintrag öffnenVosevi · 4.5 · 7 Medicinal product by Effects on medicinal product levels. therapeutic areas/Possible Mean ratio (90% confide
Eintrag öffnenVosevi · 4.5 · 8 Medicinal product by Effects on medicinal product levels. therapeutic areas/Possible Mean ratio (90% confide
Eintrag öffnenVosevi · 4.5 · 9 Medicinal product by Effects on medicinal product levels. therapeutic areas/Possible Mean ratio (90% confide
Eintrag öffnenVosevi · 4.5 · As Vosevi contains sofosbuvir, velpatasvir and voxilaprevir, any interactions that have been identified with t
Eintrag öffnenVosevi · 4.5 · As liver function may change during treatment with Vosevi, close monitoring of International Normalised Ratio
Eintrag öffnenVosevi · 4.5 · Cimetidined Nizatidined Ranitidined
Eintrag öffnenVosevi · 4.5 · Concomitant use with ethinylestradiol-containing medicinal products may increase the risk of alanine aminotran
Eintrag öffnenVosevi · 4.5 · Famotidine dosed 12 hours prior to Vosevi
Eintrag öffnenVosevi · 4.5 · Famotidine dosed simultaneously with Vosevi
Eintrag öffnenVosevi · 4.5 · Impact of DAA therapy on medicinal products metabolized by the liver
Eintrag öffnenVosevi · 4.5 · Interactions between Vosevi and other medicinal products
Eintrag öffnenVosevi · 4.5 · Medicinal product by Effects on medicinal product levels. therapeutic areas/Possible Mean ratio (90% confidenc
Eintrag öffnenVosevi · 4.5 · Medicinal products that are moderate P-gp inducers and/or moderate CYP inducers (e.g. efavirenz, modafinil, ox
Eintrag öffnenVosevi · 4.5 · Medicinal products that may decrease plasma exposure of Vosevi Medicinal products that are strong inducers of
Eintrag öffnenVosevi · 4.5 · Medicinal products that may increase plasma exposure of Vosevi Co-administration with medicinal products that
Eintrag öffnenVosevi · 4.5 · Patients receiving tenofovir disoproxil fumarate and Vosevi concomitantly should be monitored for adverse reac
Eintrag öffnenVosevi · 4.5 · Patients treated with ethinylestradiol-containing medicinal products
Eintrag öffnen